Sartorius Stedim Biotech S.A.
SDMHF
$235.80
$0.800.34%
OTC PK
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 77.74M | 48.61M | 28.03M | 51.56M | |
| Total Depreciation and Amortization | 88.41M | 40.93M | 83.77M | 80.19M | |
| Total Amortization of Deferred Charges | -- | 44.98M | -- | -- | |
| Total Other Non-Cash Items | 40.18M | 21.53M | 72.78M | 58.88M | |
| Change in Net Operating Assets | -64.58M | 147.64M | 99.60M | 42.19M | |
| Cash from Operations | 141.75M | 303.69M | 284.19M | 232.81M | |
| Capital Expenditure | -86.14M | -85.28M | -77.40M | -86.32M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -1.13M | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -213.20K | -- | -- | |
| Cash from Investing | -87.28M | -85.49M | -77.40M | -86.32M | |
| Total Debt Issued | 12.90M | 3.70M | 0.00 | 13.60M | |
| Total Debt Repaid | 0.00 | -9.10M | -29.80M | -289.30M | |
| Issuance of Common Stock | 1.10M | 2.80M | 3.10M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -5.90M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -76.15M | 0.00 | 0.00 | -72.22M | |
| Other Financing Activities | -200.00K | -8.80M | -133.10M | -27.50M | |
| Cash from Financing | -60.49M | -12.15M | -175.68M | -404.92M | |
| Foreign Exchange rate Adjustments | -3.40M | 3.30M | 219.90K | -968.70K | |
| Miscellaneous Cash Flow Adjustments | -113.50K | -- | -- | -- | |
| Net Change in Cash | -9.53M | 209.36M | 31.33M | -259.40M | |